Anti-AAV Neutralizing AntibodiesRecombinant clones targeting AAV2, AAV5, AAV8, and AAV9 VP1/capsid with validated neutralization activity. Includes anti-AAV2 intact-particle antibodies (clones A20 and A20R) validated for dot blot, ICC/IF, IP, and neutralization — widely used for empty/full capsid discrimination and pre-existing immunity screening.
Polyclonal Detection AntibodiesAnti-VP1, anti-VP2, and anti-VP3 polyclonal antibodies for AAV2, AAV3, AAV6, and AAV8 serotypes. Validated for ELISA, WB, and IHC — suitable for capsid protein expression monitoring, lot-release testing, and tissue biodistribution studies.
Capsid Recombinant ProteinsHis-tagged VP1, VP2, and VP3 proteins for AAV2, AAV3, AAV6, and AAV8. Includes a tag-free AAV8 capsid option. Validated for SDS-PAGE, WB, and ELISA — suitable as immunogens, ELISA coating antigens, and standards for anti-AAV antibody quantification assays.
AAV Receptor (AAVR/KIAA0319L)Anti-AAVR polyclonal antibody and recombinant AAVR protein (His-tagged) for studying AAV cellular entry mechanisms. AAVR is the primary attachment receptor for multiple AAV serotypes and a key target in vector tropism engineering research.
中文
English
한국어
日本語
Español
Français
Русский
